NAMI does not currently carry a credible, multi-analyst price-target set. Aggregators such as TipRanks list no usable average analyst price target, and Simply Wall St reports insufficient data for a consensus. Because no dependable analyst range exists, this discussion uses a fallback objective drawn from identifiable public commentary rather than any fabricated consensus.
Market commentary and financial-analysis summaries have pointed to a recovery toward the $2.50 area as a realistic technical and valuation milestone, describing it as a return to trading levels the stock occupied in mid-2026 before its latest leg lower. That figure is roughly 46% above the recent price, comfortably clearing the 10% minimum needed for a meaningful target, yet it remains far below the stock's former highs. It is a discussion-based reference point, not a guarantee and not an official consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At a recent verified price near $1.71, NAMI trades close to its 52-week low of about $1.51 after a dramatic slide from a high near $26.75. Reaching $2.50 would require a gain of roughly 46%, which is a very large move by any conventional measure, especially for a micro-cap with very thin average trading volume.
The path would likely depend on restoring investor confidence in the company's business model. NAMI generates revenue from digital education content but has reported net losses and negative margins in recent periods. Any durable advance would probably need to be built on evidence of narrowing losses, sustained demand for its Namibox platform and new AI learning devices, and a calmer backdrop for Chinese education-technology names, which have been prone to sharp sentiment swings.
NAMI's long-term structure is clearly negative: shares have broken a long-running downtrend and sit near the 52-week low, with little established technical support beneath the recent range. The $2.50 area functions as a meaningful resistance zone because it corresponds to mid-2026 trading levels that the stock has since surrendered. Above that, former trading ranges extend much higher, but the immediate challenge is simply holding above the low-$1.50s and reclaiming the low-$2s. For a stock with this little liquidity, technical signals carry more noise than usual and should be treated cautiously.
Because there is no robust analyst target set, there is no reliable 12-month research horizon to anchor the $2.50 objective; it should be viewed as a directional reference rather than a dated forecast. Investors should monitor the company's earnings releases and guidance, any updates on revenue growth and margin trajectory, adoption of its AI learning devices, and broader developments in China's education-technology policy. For a micro-cap, changes in share liquidity and any new institutional or strategic interest also matter. Analyst coverage could emerge over time, but none currently provides a dependable anchor.
In my own process, Tickeron's AI Daily Buy/Sell Signals provide a practical way to stay on top of fast-moving names. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and shifting conditions. For something as volatile and thinly traded as NAMI, these alerts can add discipline without replacing independent research.
Can NAMI reach $2.50? The target is not an analyst-derived figure but a public-discussion reference to mid-2026 trading levels, and it sits roughly 46% above the latest price near $1.71, making it a very large move for a loss-making micro-cap. Support could come from depressed valuation multiples, the company's content-plus-hardware expansion, and the potential for sharp mean-reversion bounces. Working against it are persistent losses, extremely thin liquidity, a clearly negative long-term chart, and exposure to China's education-policy landscape. With no credible analyst consensus available, investors should treat any price objective as highly uncertain and focus on earnings, margin trajectory, product adoption, and sector sentiment before drawing conclusions.
I often turn to Tickeron's suite of AI tools when reviewing micro-caps like this one. The AI Daily Buy/Sell Signals help surface potential shifts, while the broader platform lets me compare technical setups across similar names. These resources have become a regular part of how I organize ideas before making any decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NAMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 12 of 14 cases where NAMI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for NAMI just turned positive on November 13, 2026. Looking at past instances where NAMI's MACD turned positive, the stock continued to rise in 15 of 18 cases over the following month. The odds of a continued upward trend are 83%.
Following a +8.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAMI advanced for three days, in 41 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NAMI as a result. In 31 of 32 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NAMI entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.084) is normal, around the industry mean (0.974). P/E Ratio (0.128) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.979) among similar stocks. P/S Ratio (0.141) is also within normal values, averaging (71.888).
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. NAMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InternetSoftwareServices